SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new at-home COVID test has received emergency use authorization (EUA) ...
SAN DIEGO (KGTV) -- A San Diego company just got emergency authorization from the Food and Drug Administration to sell a self-test for COVID-19 that returns results in 10 minutes, entirely from home.
SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly ...
Quidel, a developer of rapid diagnostic testing solutions, has received an Emergency Use Authorization from the U.S. Food and Drug Administration, allowing the company to market its new QuickVue ...
San Diego’s Quidel Corp. got the green light this week for its home-use COVID-19 diagnostic test with a prescription — an incremental step toward the company’s goal of offering rapid COVID tests over ...
A San Diego-based diagnostic health care manufacturer was granted emergency approval Monday for its at-home COVID-19 test by the U.S. Food and Drug Administration and plans to ramp up production in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results